HLA Haplotypes and Relapse After Hematopoietic Cell Transplantation.

Effie W Petersdorf Caroline McKallorMari MalkkiMeilun HeStephen R SpellmanTheodore GooleyPhilip Stevenson

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)

HLA class II haplotypes may be functional constituents of the transplantation barrier, and their consideration in patients and donors may improve the success of transplantation.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
cell therapy
patient reported outcomes
mesenchymal stem cells